Wrap up: Animal health company responds to safety concerns over OA drug, and other veterinary news


Check out this week’s headlines



Good afternoon dvm360 readers! We hope you are as excited about today being Friday as we are and ready to take on the weekend. We are now officially less than a month from our first Fetch conference in Nashville, Tennessee. Join us in the Music City from May 17-18 to earn over 14 continuing education credits. This is Fetch’s first time in Nashville so secure your spot here today!

As we prepare for Fetch Nashville, here is what was popular this week on dvm360.com:

  • After pet owners spoke out over claims that Zoetis’ bedinvetmab injection (Librela) and frunevetmab injection (Solensia) products caused pets to be sick instead of improving, Zoetis and other veterinary professionals speak out about the drugs and what they have experienced.
  • On this Wednesday’s episode of The Vet Blast Podcast, Ken Yagi, MS, RVT, VTS (ECC), (SAIM), explains to listeners why it is important to make an emergency room a low stress experience for both patient and client, and how to accomplish that.
  • Azalia Boyd, DVM, shared a closer look at the work she is doing to help progress the veterinary profession through her work as the chief veterinary medical officer for Companions and Animals for Reform and Equity’s Urban Community Animal CARE Division in this Veterinary Profile from our April print publication.
  • During an interview with dvm360, Deb Zoran, DVM, PhD, director of the Texas A&M Veterinary Emergency Team (VET), discussed more about what the team responded do during its deployment to the Texas panhandle, where the Smokehouse Creek wildfire burned.
  • Domer Technology announced the launch of 2 new laser to its product line, Domer Laser Class 3B cold laser therapy device and high intensity call 4 laser. The products can help veterinary professionals manage pain for tendon injuries, post-surgical or trauma wounds, nerve injury, and more.
  • And more!
Related Videos
© 2024 MJH Life Sciences

All rights reserved.